Liloglou T, Scholes A G, Spandidos D A, Vaughan E D, Jones A S, Field J K
Molecular Genetics and Oncology Group, Clinical Dental Sciences, The University of Liverpool, United Kingdom.
Cancer Res. 1997 Sep 15;57(18):4070-4.
We examined the p53 mutational profile of 65 squamous cell carcinomas of the head and neck (SCCHNs) from patients living in northwest England. Twenty-three p53 mutations were detected in 20 samples (31%). GC-->AT transitions were the predominant type of mutation. The p53 mutational profile of SCCHN tumors was similar to that of non-small cell lung tumors from patients within the same geographical area, supporting the idea of a common model for carcinogenesis in the upper respiratory tract. Statistical analysis showed that the incidence of p53 mutations among present and former smokers was significantly higher than that in nonsmokers (P < 0.02). In addition, p53 mutations were found to predominate in a group of SCCHN patients with low genetic damage, as indicated by the fractional allelic loss value. The above findings suggest an early initiating role for p53 and imply that at least two separate carcinogenic pathways may be involved in the development of SCCHN.
我们检测了居住在英格兰西北部患者的65例头颈部鳞状细胞癌(SCCHN)的p53突变情况。在20个样本中检测到23个p53突变(31%)。GC→AT转换是主要的突变类型。SCCHN肿瘤的p53突变情况与同一地理区域患者的非小细胞肺癌相似,支持上呼吸道致癌共同模式的观点。统计分析表明,现吸烟者和既往吸烟者中p53突变的发生率显著高于不吸烟者(P<0.02)。此外,如通过等位基因缺失分数值所示,p53突变在一组遗传损伤较低的SCCHN患者中占主导。上述发现表明p53具有早期启动作用,并暗示至少两条独立的致癌途径可能参与SCCHN的发生发展。